Hemorrhage control requires hemostatic materials that are both efective and biocompatible.Among these,diatom biosilica(DBs)could signifcantly improve hemorrhage control,but it induces hemolysis(the hemolysis rate>5...Hemorrhage control requires hemostatic materials that are both efective and biocompatible.Among these,diatom biosilica(DBs)could signifcantly improve hemorrhage control,but it induces hemolysis(the hemolysis rate>5%).Thus,the purpose of this study was to explore the infuence of Ca^(2+)biomineralization on DBs for developing fast hemostatic materials with a low hemolysis rate.Here,CaCl_(2)was added to the diatom medium under high light(cool white,fuorescent lamps,67.5µmol m^(−2) s^(−1)),producing Ca-DBs-3 with a particle size of 40-50μm and a Ca^(2+)content of Ca-DBs-3 obtained from the higher concentration CaCl_(2)group(6.7 mmol L^(−1))of 0.16%.The liquid absorption capacity of Ca-DBs-3 was 30.43±0.57 times its dry weight;the in vitro clotting time was comparable to QuikClot®zeolite;the hemostatic time and blood loss using the rat tail amputation model were 36.40±2.52 s and 0.39±0.12 g,which were 40.72%and 19.50%of QuikClot®zeolite,respectively.Ca-DBs-3 showed no apparent toxicity to L929 cells(cell viability>80%)and was non-hemolysis(the hemolysis rate<2%).This study prepared Ca-DBs-3 with a rapid hemostatic efect and good biocompatibility,providing a path to develop diatom biosilica hemostatic materials.展开更多
基金The work was supported by National Natural Science Foundation of China(U22A20588,82172095)Shandong Provincial Natural Science Foundation(ZR2019QD005)Qingdao Science and Technology Demonstration and Guidance Project(20-3-4-50-nsh).
文摘Hemorrhage control requires hemostatic materials that are both efective and biocompatible.Among these,diatom biosilica(DBs)could signifcantly improve hemorrhage control,but it induces hemolysis(the hemolysis rate>5%).Thus,the purpose of this study was to explore the infuence of Ca^(2+)biomineralization on DBs for developing fast hemostatic materials with a low hemolysis rate.Here,CaCl_(2)was added to the diatom medium under high light(cool white,fuorescent lamps,67.5µmol m^(−2) s^(−1)),producing Ca-DBs-3 with a particle size of 40-50μm and a Ca^(2+)content of Ca-DBs-3 obtained from the higher concentration CaCl_(2)group(6.7 mmol L^(−1))of 0.16%.The liquid absorption capacity of Ca-DBs-3 was 30.43±0.57 times its dry weight;the in vitro clotting time was comparable to QuikClot®zeolite;the hemostatic time and blood loss using the rat tail amputation model were 36.40±2.52 s and 0.39±0.12 g,which were 40.72%and 19.50%of QuikClot®zeolite,respectively.Ca-DBs-3 showed no apparent toxicity to L929 cells(cell viability>80%)and was non-hemolysis(the hemolysis rate<2%).This study prepared Ca-DBs-3 with a rapid hemostatic efect and good biocompatibility,providing a path to develop diatom biosilica hemostatic materials.
